PSMB8 and leukemia: Exploiting this alternative mechanism of targeting transcriptional oncogenic networks, we demonstrate that combination of pharmacologic PSMB8- and Menin-inhibition results in synergistic abrogation of human leukemic cells in vivo and improved elimination of leukemia initiating cells in pre-clinical PDX-models when compared to Menin-inhibitor treatment alone.